Clinical Trials Logo

Clinical Trial Summary

The iParent2Parent program matches parents of children living with arthritis with a trained parent mentor who will provide parents of children newly diagnosed with arthritis: practical coping advice and social support through shared lived experiences. This study will compare two groups of parents: those who are in the iParent2Parent program and those in the control group (no mentor).


Clinical Trial Description

Parents/primary caregiver of children with JIA are an often overlooked but essential member of their child's health care team. They are responsible for managing their child's treatment program, and act as advocates for their child to support positive adaptation to JIA and to learn self-management skills for the disease. This is in the context of managing the financial, logistical, emotional, and social demands of parenting in general. Within pediatric tertiary care centres, peer-support programs for parents of children with JIA are often limited or difficult to access. The iParent2Parent Program aims to fill this gap in services by offering a program of trained parent peer mentors who can provide practical coping advice, foster adaptive problem solving, and provide social support via shared lived experience. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04168034
Study type Interventional
Source The Hospital for Sick Children
Contact
Status Completed
Phase N/A
Start date August 15, 2019
Completion date March 16, 2020

See also
  Status Clinical Trial Phase
Completed NCT05603286 - Using Self-evaluation to Increase Visit Intervals in Juvenile Idiopathic Arthritis N/A
Active, not recruiting NCT03816397 - Adalimumab in JIA-associated Uveitis Stopping Trial Phase 4
Completed NCT00783510 - Juvenile Idiopathic Arthritis (JIA) Registry
Not yet recruiting NCT05688358 - Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
Completed NCT06284616 - JASP-1 for Children Recently Diagnosed and Their Parents N/A